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Abstract
Objective: Diabetes mellitus is associated with cognitive deficits and an increased risk of dementia, particularly in the
elderly. These deficits and the corresponding neurophysiological structural and functional alterations are linked to both
metabolic and vascular changes, related to chronic hyperglycaemia, but probably also defects in insulin action in the brain.
To elucidate the specific role of brain insulin signalling in neuronal functions that are relevant for cognitive processes we
have investigated the behaviour of neurons and synaptic plasticity in the hippocampus of mice lacking the insulin receptor
substrate protein 2 (IRS-2).
Research Design and Methods: To study neuronal function and synaptic plasticity in the absence of confounding factors
such as hyperglycaemia, we used a mouse model with a central nervous system- (CNS)-restricted deletion of IRS-2
(NesCreIrs2KO).
Results: We report a deficit in NMDA receptor-dependent synaptic plasticity in the hippocampus of NesCreIrs2KO mice, with
a concomitant loss of metaplasticity, the modulation of synaptic plasticity by the previous activity of a synapse. These
plasticity changes are associated with reduced basal phosphorylation of the NMDA receptor subunit NR1 and of
downstream targets of the PI3K pathway, the protein kinases Akt and GSK-3b.
Conclusions: These findings reveal molecular and cellular mechanisms that might underlie cognitive deficits linked to
specific defects of neuronal insulin signalling.
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Introduction
Substantial epidemiological evidence supports an association
between diabetes mellitus and cognitive impairment [1–3]. Animal
models of diabetes exhibit impaired learning and memory [4–8],
effectively prevented by administration of insulin [4,6]. Insulin, its
related peptide, insulin-like growth factor-1 (IGF-1), and their
receptors (IRs and IGF-1Rs) show abundant expression throughout
the CNS. Especially high levels can be found in brain regions that are
involved in higher cognitive functions, such as the hippocampus
[9,10]. However, diabetic rodent models and human patients are
susceptible to suffer complex effects of systemic hyperglycaemia and
glucose intolerance, such as vascular disorders, hypertension and heart
disease, which can independently exacerbate cognitive impairment
[1]. This makes it difficult to dissect the potential role of brain insulin
signalling in cognition and its cellular and molecular mechanisms.
IR/IGF-1R are tyrosine kinases that activate downstream
targets by phosphorylating insulin receptor substrate (IRS)
proteins [11–14]. IRS-1 and IRS-2 are widely expressed in the
brain [15–19]. Phosphorylation of IRS proteins leads to activation
of the phosphatidylinositol-3 kinase (PI3K) and mitogen-activated
protein kinase (MAPK/ERK) pathways [20–23]. Interestingly,
these pathways are also involved in the induction/expression of
hippocampal synaptic plasticity changes, such as long-term
potentiation (LTP) [24–29], which is compromised in experimen-
tal models of diabetes [5,6,8,30–34].
Although the contribution of specific IRS subtypes to neuronal
synaptic function that is relevant for cognition has not been firmly
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31124established, previous work indicate a predominant role of IRS-2 in
the control of brain anatomy and metabolic pathways that are
important for synaptic plasticity and cognitive processes under
normal and pathological conditions ([35–38]; but see [39]). In the
present study, we have therefore questioned the role of neuronal
IRS-2 in hippocampal synaptic function and plasticity by using a
mouse model with a central nervous system- (CNS)-restricted
deletion of IRS-2 (NesCreIrs2KO). In NesCreIrs2KO mice, IRS-2 is
absent in CNS progenitor derived cells (neurons), while its
expression is normal in other tissues [18,40]. While mice globally
lacking IRS-2 develop diabetes due to insulin resistance and
pancreatic b cell dysfunction [41], NesCreIrs2KO mice do not suffer
from overt and progressive diabetes due to preservation of
pancreatic b-cell mass and insulin concentration [18,40]. Ne-
sCreIrs2KO mice therefore permit the investigation of the role of
IRS-2 signalling in neurons in the absence of some confounding
factors such as systemic hyperglycemia.
Results
Deficiency in IRS-2 does not affect intrinsic excitability of
hippocampal CA1 neurons
Insulin/IGF-1 modulate membrane excitability and firing of
hippocampal neurons by affecting various potassium and calcium
conductances [42–46]. We therefore investigated whether neuronal
IRS-2regulates intrinsic membrane properties and firingpatternsof
hippocampal neurons. NesCreIrs2KO mice were generated and
shown to lack IRS-2 expression in the brain [40]. No alteration in
the hippocampal expression of IRS-1 was detected by RT-PCR in
these animals (IRS-1 in NesCreIrs2KO mice: 99.3614.2% of control;
n=5). Whole-cell recordings revealed no significant differences in
the resting membrane potential (Fig. 1A) and membrane resistance
(Fig. 1B) of CA1 pyramidal neurons from NesCreIrs2KO mice and
littermate controls. Furthermore, there were no differences in
neuronal firing in response to somatic current injections (Fig. 1C),
instantaneous firing frequency (data not shown) and spike frequency
adaptation (Fig. 1D). A brain-specific deficit in IRS-2 has therefore
no significant impact upon the passive or active membrane
properties of CA1 pyramidal neurons.
NMDA receptor-mediated short-term plasticity (STP) is
impaired in adult NesCreIrs2KO mice
Although insulin/IGF-1 have been shown to modulate
glutamate receptor expression and activity [47–51] and synaptic
plasticity [52–55], the downstream signalling pathways involved
are not well understood. We specifically asked whether the IRS-2
deletion affected hippocampal synaptic transmission. Stimulation
of the Schaffer collateral-commissural fibres (0.033 Hz) identified
no difference in basal synaptic transmission at CA1 synapses of
NesCreIrs2KO and control mice (data not shown). Long-term
potentiation (LTP) is an activity-dependent model of synaptic
plasticity, which is widely considered as a cellular correlate of
Figure 1. Intrinsic excitability of hippocampal neurons is not altered in adult NesCreIrs2KO mice. A–B: Neither resting membrane
potential (RMP; A) or membrane resistance (Input Resistance; B) showed significant differences between CA1 pyramidal neurons of NesCreIrs2KO
mice (2/2; 26766 mV; 229617 MV, N=11, n=20) and littermate controls (+/+; 26765 mV; 248627 MV, N=14, n=22). C: A similar number of
action potentials were generated in response to 1 s-long current injections to CA1 neurons of control (+/+; 160 pA: 3.160.7; 200 pA: 4.160.8; 240 pA:
4.460.7) and NesCreIrs2KO (2/2; 160 pA: 2.860.5; 200 pA: 4.160.6; 240 pA: 5.260.8) mice. D: Sample traces taken from representative experiments
in CA1 neurons of control (+/+; RMP: 258 mV) and NesCreIrs2KO (2/2; RMP: 260 mV) mice, illustrate the response to a 1 s-long injection of 200 pA.
Scale bars: 20 mV, 200 ms.
doi:10.1371/journal.pone.0031124.g001
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deficient or defective insulin signalling [5,6,8,30–34]. We assessed
whether neuronal IRS-2 plays a specific role in LTP, elicited in
CA1 synapses of adult mice (5–10 months old) by high-intensity
theta burst stimulation (H-TBS, see Methods) of Schaffer
collateral-commissural fibres. The H-TBS stimulation protocol
reliably induced LTP in all slices from adult mice. The resulting
LTP persisted for at least 60 minutes and was prevented by the
application of the NMDA receptor antagonist DL-AP5 (100 mM)
and Ca
2+ channel blocker nimodipine (30 mM; n=4; data not
shown) in control mice. The LTP induced by H-TBS was of
similar magnitude in control and NesCreIrs2KO mice (Fig. 2A).
However, the short-term potentiation (STP) of the EPSPs
measured 2 minutes after H-TBS was significantly reduced in
NesCreIrs2KO mice (Fig. 2B). The difference in STP was not due to
presynaptic changes, since paired-pulse facilitation (PPF) was
unchanged before and after H-TBS in either control or
NesCreIrs2KO mice, suggesting that the probability of neurotrans-
mitter release was not modified by the IRS-2 deficiency (Fig. 2C
and D). To further confirm that the STP following H-TBS was of
postsynaptic origin and dependent on the activation of NMDA
receptors, we applied H-TBS in the presence of DL-AP5 (50 mM).
DL-AP5 significantly reduced STP in control mice (Fig. 2E). In
contrast, in NesCreIrs2KO mice DL-AP5 did not affect the
amplitude and slope of the EPSPs measured 2 min following the
H-TBS (Fig. 2F). The lack of effect of DL-AP5 is likely to be due
to an impairment of NMDA receptor function underlying the H-
TBS-induced STP in NesCreIrs2KO mice.
LTP and glutamatergic transmission are altered in CA1
synapses of adult NesCreIrs2KO mice
Next, we facilitated the induction of synaptic plasticity in adult
mice by suppressing fast inhibitory synaptic transmission. Upon
application of the GABAA receptor antagonist SR95531 (6 mM), a
single TBS was sufficient to produce a substantial LTP in CA1
synapses of control mice (Fig. 3A and B, upper traces).
However, the level of LTP was significantly reduced in
NesCreIrs2KO mice (Fig. 3A and B, lower traces). Therefore,
in response to a weaker induction protocol delivered upon
inhibition of GABAA receptors, NesCreIrs2KO mice show an
impaired level of LTP with respect to their control littermates.
NMDA receptor activation is essential for the induction of LTP
at Schaffer collateral-CA1 synapses [58,59], also in response to
TBS [60]. Changes in NMDA receptor function and expression
have been described in animal models of diabetes [61,62] and as a
direct response to application of insulin [47–51]. To test whether
alterations in the NDMA-dependent synaptic transmission were
responsible for the reduced LTP in mice lacking neuronal IRS-2,
we analysed AMPA- and NMDA-mediated excitatory post-
synaptic currents (EPSCs) evoked by stimulation of the Schaffer
collateral-commissural fibres after blocking GABAA-mediated
transmission and recorded at a holding potential of 270 mV
and +40 mV, respectively. The ratio of NMDA- to AMPA-
mediated EPSC amplitude was significantly lower in NesCreIrs2KO
(Fig. 3C and D, right) compared to littermate controls (Fig. 3C
and D, left). The lower ratio of NMDA- to AMPA-mediated
EPSC amplitude in NesCreIrs2KO mice could be due to changes in
either the expression or activity of AMPA and NMDA receptors.
Spontaneous excitatory synaptic activity, corresponding to mini-
ature and spontaneous action potential-driven events, was entirely
dependent on AMPA receptor activation in our recordings, since it
was fully suppressed by application of the AMPA receptor
antagonist NBQX (5 mM). We analyzed the amplitude of all
spontaneous events recorded at 270 mV (n=12 cells from 5 wild-
type and n=11 cells from 6 NesCreIrs2Ko mice). The mean
amplitude of spontaneous events in wild-type CA1 neurons was
13.560.3 pA (n=438); in NesCreIrs2Ko cells, 13.460.3 pA
(n=561; p=0.76). This indicates that basal synaptic AMPA
receptor function is unlikely to be changed (i.e. increased) in
NesCreIrs2Ko mice. Additionally, NBQX (5 mM) had a small effect
on the EPSCs recorded at +40 mV, a potential at which the
contribution by NMDA receptor activation is predominant. In 13
CA1 pyramidal neurons, NBQX caused a reduction in the current
peak amplitude by 16.164.9%. The reduction caused by NBQX
on wild-type cells (15.165.9%, n=9) was not statistically different
from that in NesCreIrs2KO cells (18.3610.2%, n=4; p=0.78).
Although indirect, this result suggests that NBQX had a similar
impact on the EPSCs measured at +40 mV in wild-type and
NesCreIrs2KO mice, supporting the notion that their AMPA-
mediated component was similar. Finally, after assessing that the
NMDA contribution to the amplitude of extracellularly recorded
fEPSPs was negligible by evaluating the effects of DL-AP5 (50–
100 mM) at different time points (change in fEPSP amplitude the
presence of DL-AP5: peak, 8.464.6%, p=0.11; 20 ms post-
stimulus, 1.769.1%, p=0.85; 30 ms post-stimulus, 212.466.4%,
p=0.09; n=9), we compared input-output curves of fEPSPs
obtained from control and NesCreIrs2KO mice. When plotted
against stimulus intensity or indeed fibre volley amplitude, no
strain-specific differences were observed (not shown). This finding
further supports the idea that there is no difference in basal AMPA
receptor function in NesCreIrs2KO. As a further, independent line
of evidence highlighting potential differences in AMPA and
NMDA receptors under basal conditions, we carried out a
western-blot protein analysis in lysates from the hippocampal
CA1 subfield of both control and NesCreIrs2KO mice. There was no
significant alteration in the total amount of the AMPA receptor
subunit GluR1 between genotypes (Fig. 3E–F, upper panels).
Additionally, the proportion of phosphorylated GluR1 subunit
(pGluR1) at Ser845 (Fig. 3E) and Ser831 (Fig. 3F) relative to
total GluR1 protein was comparable in controls and NesCreIrs2KO
mice. Similarly, there were no changes in the total levels of the
NMDA receptor subunits NR1 (Fig. 3G, upper panel), NR2A
(Fig. 3H) and NR2B (Fig. 3I). Conversely, NesCreIrs2KO mice
displayed a significant reduction in the relative proportion of NR1
subunit phosphorylated at Ser897 (pNR1) relative to their control
littermates (Fig. 3G). Since phosphorylation of NR1 at Ser897 is
known to increase the activity of NMDA receptors [63–68], the
reduced phosphorylation observed in NesCreIrs2KO mice may
underlie the lower ratio of NMDA- to AMPA-mediated EPSC
amplitude, and contribute to the attenuation of LTP in the
absence of neuronal IRS-2.
LTP and phosphorylation of Akt/protein kinase B and
glycogen synthase kinase-3 (GSK-3) are impaired in CA1
of juvenile NesCreIrs2KO mice
To assess whether IRS-2 affects NMDA-dependent synaptic
plasticity also in the presence of intact inhibitory transmission, we
performed recordings from younger, naive mice (3–6 weeks) in the
absence of GABAA receptor antagonists. A single TBS induced
reliable LTP in control mice, but an attenuated one in juvenile
NesCreIrs2KO mice (Fig. 4A and B). These results provide further
indication that plasticity of CA1 synapses is impaired in
NesCreIrs2KO mice in a way that is independent of age and
experience.
The molecular mechanisms underlying NMDA-dependent LTP
involve several protein kinases, including phosphatidylinositol 3-
kinase (PI3K) and mitogen-activated protein kinases (MAPK/
ERK) (for reviews see [57,69,70]). Activation of IRS proteins is
IRS-2 Regulates Hippocampal Synaptic Plasticity
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e31124Figure 2. NMDA receptor-mediated short-term plasticity (STP) is impaired in adult NesCreIrs2KO mice. A: High-intensity theta burst
stimulation (H-TBS) was applied to Schaffer collateral-commissural fibres following at least 15 minutes of stable baseline recording of synaptic activity
in slices from 5–10 month old mice that had previously undergone behavioural training. In the absence of GABA receptor inhibitors, H-TBS induced
robust long-term potentiation (LTP) of similar magnitude in both control (+/+; 16067%, N=7, n=10) and NesCreIrs2KO mice (2/2; 15266%, N=5,
n=7), when measured 60 min following induction. Recordings made following H-TBS commence at time 0. B: Graph illustrates the same data as in A,
but on an expanded time scale. The STP measured 2 min following H-TBS was significantly reduced in adult NesCreIrs2KO mice (2/2; average EPSP
slope change: 11065%, N=5, n=7) compared with that recorded from littermate controls (+/+; average EPSP slope change: 13466%, N=7, n=10,
p,0.01) during the same post-stimulus period. Insets illustrate typical EPSP traces (average of 4 consecutive sweeps) recorded immediately prior to,
and either 60 min (A) or 2 min (B) following H-TBS in either control (+/+)o rNesCreIrs2KO (2/2) mice. C: No significant change in paired-pulse
facilitation (PPF) was observed following H-TBS in either control (pre H-TBS: 1.760.1; post H-TBS: 1.660.1; N=5, n=6) or NesCreIrs2KO mice (pre H-
TBS: 1.660.2; post H-TBS: 1.560.1; N=4, n=5). Similarly, during the 2 min immediately following H-TBS, there was no significant difference in PPF
between genotypes (+/+: 1.660.1; 2/2: 1.560.1). D: Representative PPF traces (average of 4 consecutive sweeps) taken from single experiments
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p38MAPK and PI3K [20,21,23,71–73]. We therefore assessed
whether the absence of IRS-2 in hippocampal neurons affects
these signalling pathways. Under basal conditions, phosphoryla-
tion of p38MAPK at Thr180/Tyr182 was unaltered in CA1
lysates from NesCreIrs2KO compared to control mice (Fig. 4C).
Similarly, Western blot analysis revealed that the activity of ERK,
assessed by the phosphorylation levels at Thr202 and Tyr204, was
similar in control and NesCreIrs2KO mice (Fig. 4D). Interestingly,
however, phoshosphorylation of Akt/protein kinase B, a main
downstream effector of PI3K, was substantially reduced at two
distinct phosphorylation sites, Thr308 and Ser473, in NesCreIrs2KO
mice (Fig. 4E). A prominent target for PI3K-Akt signalling is
glycogen synthase kinase-3 (GSK-3), a regulator of hippocampal
synaptic plasticity [74,75]. We therefore investigated the phos-
phorylation state of the beta isoform of GSK-3 (GSK-3b) at Ser9,
which has an inhibitory effect and is commonly used as a measure
of GSK-3b activity [76,77]. Consistent with a reduction in
phospho-Akt, we found that phosphorylation of GSK-3b at Ser9
was significantly reduced in CA1 lysates of NesCreIrs2KO mice,
suggesting an enhancement of GSK-3b activity (Fig. 4F). Our
results show that the lack of neuronal IRS-2 is associated with a
reduction in NMDA-dependent LTP at CA1 synapses. This
plasticity deficit correlates with IRS-2-dependent alterations in the
PI3K signalling pathway, leading to a reduced activity of Akt/
protein kinase B and, consequently, to an increased GSK-3b
activity in hippocampal neurons.
Metaplasticity of CA1 synapses is inhibited by deletion of
IRS-2
At hippocampal synapses different activation patterns result in
NMDA receptor signals that induce either LTP or long-term
depression (LTD) of synaptic efficacy [56,57], whose interplay can
be critically regulated by GSK-3b [75]. Induction of NMDA-
dependent LTP triggers the PI3K-Akt pathway, which in turn
inhibits GSK-3b. In the inhibited state, GSK-3b can prevent the
induction of LTD for up to one hour following LTP induction [75]
in what can be regarded as a form of metaplasticity [78]. As GSK-
3b activity is up-regulated in IRS-2-deficient neurons (Fig. 4F), it
is conceivable that metaplasticity at CA1 synapses may be altered
in NesCreIrs2KO mice. A priming stimulus (10 Hz) was applied to
the synapses 20–30 minutes prior to TBS and did not itself
produce a sustained alteration in synaptic efficacy, yet significantly
inhibited subsequent LTP induction in juvenile control mice for at
least 50 minutes (Fig. 5A). However, the same priming stimulus
failed to alter the magnitude of LTP evoked in juvenile
NesCreIrs2KO mice (Fig. 5B). This finding suggests that there is a
deficit of metaplasticity in CA1 synapses of mice lacking neuronal
IRS-2 in response to a conditioning stimulus capable of completely
preventing LTP in control animals.
Common experimental procedures to induce metaplasticity
involve pharmacological or synaptic activation of NMDA
receptors [78]. The reduced contribution of NMDA receptor-
mediated current to synaptically induced EPSCs in Ne-
sCreIrs2KO mice (Fig. 3C and D) might therefore play a role
in the metaplasticity deficit observed in neurons lacking IRS-2
(Fig. 5A and B). We therefore asked whether pharmacological
potentiation of NMDA receptor activity would induce meta-
plasticity in mice lacking neuronal IRS-2 by overcoming the
partial loss of NMDA current in response to synaptic
stimulation. To potentiate NMDA responses, the extracellular
concentration of Mg
2+ was lowered from 1.5 mM to 1 mM,
and the extracellular concentration of Ca
2+ raised from 2 mM
to 3 mM. Under these conditions, LTP induced by a single
TBS in CA1 synapses of juvenile control mice was substantially
attenuated 60 minutes following induction (Fig. 5C). Under
the same ionic conditions, however, no alteration in the level of
LTP was observed in NesCreIrs2KO mice compared with
standard ionic conditions (Fig. 5D). Interestingly, the magni-
tude of the LTP measured in control slices upon enhancement
of NMDA receptor activity was similar to that recorded in
NesCreIrs2KO mice (Fig. 5E and F). Stimulus-evoked meta-
plasticity could still be induced in control mice under
conditions of increased NMDA receptor activity due to lower
extracellular Mg
2+ and higher concentration of Ca
2+.U n d e r
these conditions, a short priming stimulus of lower frequency
(5 Hz, applied 20 minutes prior to TBS) did not yield a
sustained, significant alteration in synaptic transmission, but
subsequently induced LTP was further reduced (Fig. 6A). This
stimulus-induced metaplasticity was prevented by applying DL-
AP5 (100 mM) during the priming period (n=3; data not
shown), confirming an involvement of NMDA receptors in its
induction. Nonetheless, in NesCreIrs2KO s y n a p s e st h es a m e5H z
priming procedure failed to cause a reduction in subsequently
induced LTP (Fig. 6B). Therefore, in mice lacking neuronal
IRS-2 enhancing NMDA receptor activity did not change LTP
compared to conditions where NMDA receptor activity was not
enhanced, and did not induce any further metaplasticity. By
contrast, enhancement of NMDA receptor activity was
sufficient to induce metaplasticity in control animals, followed
by a significant reduction in subsequently induced LTP.
Moreover, NesCreIrs2KO mice lacked NMDA receptor-depen-
dent, stimulus-evoked metaplasticity induced by low-frequency
conditioning stimuli.
Discussion
In this study, we have shown that brain deficiency of IRS-2 has
a strong impact on NMDA receptor-dependent synaptic trans-
mission, plasticity and metaplasticity in the CA1 region, which is
associated with reduced basal phosphorylation of the NMDA
receptor subunit NR1 and of downstream targets of the PI3K
pathway, such as Akt/protein kinase B and GSK-3b.
Despite the reported effects of insulin/IGF-1-mediated signal-
ling on the modulation of neuronal ion channels [42–46,79,80],
deletion of IRS-2 does not appear to affect the intrinsic excitability
of CA1 pyramidal neurons under basal conditions. Compensation
by upregulation of IRS-1 is an unlikely explanation for this result,
as levels of hippocampal IRS-1 RNA remain unchanged in
NesCreIrs2KO mice. Our results therefore suggest that IRS-1
mediated signalling might be sufficient to maintain normal
intrinsic excitability in CA1 pyramidal neurons.
carried out on a control (+/+) and NesCreIrs2KO (2/2) slice. EPSP traces are averages of 2 min recording immediately prior to, and following H-TBS. E:
In the presence of the NMDA receptor antagonist DL-AP5 (50 mM), STP, measured 2 min following H-TBS, was significantly impaired in control mice
(+/+ AP5; average EPSP slope change: 89610%, N=3, n=5) compared with values obtained in the absence of DL-AP5 (+/+ control; average EPSP
slope change: 13466%, N=7, n=10, p,0.01). F: DL-AP5 had no significant effect on STP in NesCreIrs2KO mice (2/2)( 2/2 AP5; average EPSP slope
change: 111612%, N=3, n=5), compared with STP values obtained in the absence of DL-AP5 (2/2 control; average EPSP slope change: 11064%,
N=5, n=6). Arrows indicate application of H-TBS.
doi:10.1371/journal.pone.0031124.g002
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e31124Figure 3. TBS-induced LTP and the NMDA- to AMPA-mediated EPSC ratio are reduced in adult NesCreIrs2KO mice. A: In the presence of
the GABAA receptor antagonist SR95531 (6 mM), LTP was reliably induced in control mice (+/+; average EPSP slope change 60 min after induction:
15166%, N=4, n=6) in response to a single theta-burst protocol (TBS). The level of LTP produced under the same conditions, 60 min following TBS,
was significantly reduced in NesCreIrs2KO mice (2/2; average EPSP slope change 60 min after induction: 12366%, N=4, n=5, p,0.005). Arrow
indicates application of TBS. B: Sample EPSP traces (average of 4 consecutive sweeps) from individual experiments, taken prior to, and 60 min
following TBS in control (+/+) and NesCreIrs2KO (2/2) mice. C: In the presence of SR95531 (6 mM), the ratio of NMDA-EPSC amplitude (holding
potential: +40 mV) to AMPA-EPSC amplitude (holding potential: 270 mV) was significantly lower in NesCreIrs2KO (2/2; 0.3260.04, N=6, n=11)
compared to littermate controls (+/+; 0.4460.04, N=5, n=12, p,0.05). D: EPSC traces (average of 10 consecutive sweeps) from whole-cell patch
clamp experiments in NesCreIrs2KO (2/2) and control mice (+/+) illustrating the NMDA-EPSC (measured at a holding potential of +40 mV) and
corresponding AMPA-EPSC (measured at a holding potential of 270 mV). NMDA-EPSC amplitude was measured 50 ms following stimulation to
IRS-2 Regulates Hippocampal Synaptic Plasticity
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31124The neuronal deficit in IRS-2 did however lead to a substantial
impairment of NMDA receptor-mediated short-term (STP) and
long-term potentiation (LTP) in Schaffer collateral-commissural
synapses. Furthermore, we have identified a reduced contribution
of NMDA receptors to glutamatergic transmission at CA1
synapses in NesCreIrs2KO mice, associated with a reduction in the
basal level of phosphorylation of the NR1 subunit. It is well
established that alterations in postsynaptic Ca
2+ are necessary to
evoke persistent changes in synaptic efficacy, such as LTP [81,82].
In hippocampal CA1 synapses, NMDA receptor activation is a
critical step in this process [58,83]. The NR1 subunit is an integral
component of all native NMDA receptors, and can be phosphor-
ylated by protein kinases, such as PKC on Ser896 and PKA on
Ser897, to potentiate receptor function [63–68,84,85]. The
reduced phosphorylation of the NR1 subunit at Ser897 (Fig. 3G)
is likely to lead to the decrease in activity of NMDA receptors
observed in NesCreIrs2KO mice, and might be accountable, at least
in part, for the impairment observed in synaptic plasticity. The
deficit in hippocampal LTP correlates well to previous studies
carried out on experimental models of diabetes [5,6,8,30–34], in
this case with the advantage that the restricted loss of IRS-2 in
neurons eliminates hyperglycaemia as a confounding systemic
complication associated with diabetes [86–88]. It is worthy to
notice that a previous study has shown that IRS-2 deficient mice
have enhanced hippocampal spatial reference memory, working
memory and contextual- and cued-fear memory [89]. Our finding
that basal excitatory synaptic transmission and LTP are intact in
5–10 months old, behaviourally trained NesCreIrs2KO mice
(Fig. 2A) is compatible with a lack of deficit in hippocampal
learning and memory in IRS-2 deficient mice. The plasticity
deficits that we have characterized in this study were evident in
younger, untrained animals (Fig. 4) or in older, trained ones upon
suppression of GABAergic inhibition (Fig. 3). Considering the
well documented facilitatory effect of insulin on GABA receptor
surface expression and function [90–93], this leads us to speculate
that a gradually developing, compensatory attenuation of
inhibitory transmission might have contributed to the enhance-
ment in hippocampal-dependent learning observed in Ne-
sCreIrs2KO mice [89]. This study establishes for the first time a
direct role for IRS-2 in modulating NMDA receptor-dependent
synaptic plasticity, via regulation of NR1 phosphorylation.
However, facilitating NMDA receptor activity through manipu-
lation of ionic conditions was not itself sufficient to bring the LTP
in NesCreIrs2KO mice to the same level as observed in control
animals under standard ionic conditions (compare Fig. 5C, closed
symbols, and 5D, open symbols), revealing the involvement of
downstream NMDA receptor-mediated molecular processes.
IRS-2 deficiency might indeed lead to deficits in NMDA-
dependent hippocampal synaptic plasticity by causing multiple
alterations of NMDA receptor post-translational modifications and
function. While our study shows normal total levels of NR1,
NR2A and NR2B subunits and a lower level of basal
phosphorylation of NR1 at Ser897 in NesCreIrs2Ko mice, a study
by Martin and colleagues [94], published while this paper was
under revision, supports our findings on the total level of NR2A
and NR2B subunits being normal in global IRS-2 KO mice.
However, they found a reduced tyrosine phosphorylation of NR2B
subunits following LTP induction and a reduced effect of the
NR2B specific antagonist ifenprodil on NMDA-EPSCs in global
IRS-2 KO mice [94]. The findings in our and in Martin’s study
[94] are largely complementary and provide convergent lines of
evidence supporting NMDA receptor dysfunction as a conse-
quence of IRS-2 deficiency and a potential cause for synaptic
plasticity deficits in IRS-2 deficient mice.
The signal transduction pathways downstream of NMDA
receptor activation, which underlie LTP, include the PI3K [26–
28,95,96] and MAPK/ERK pathways [57,69,70]. Both the PI3K
and MAPK/ERK pathways are further implicated in the insulin/
IGF-1-mediated modulation of synaptic function in several
neurons [54,55,97,98], and are prominent targets of IRS proteins
[20,21,23,71]. Furthermore, in knockout mice expressing a brain-
restricted insulin receptor deficiency (NIRKO) brain insulin
resistance impairs insulin-mediated activation of either the
PI3K/Akt/GSK-3b or MAPK/ERK pathways in cerebellar
granule cells [23]. In NesCreIrs2KO mice the basal activity of
p42/44 MAPK is not affected, while phosphorylation of the
downstream target of PI3K, Akt/protein kinase B, is substantially
reduced, providing a further potential mechanism for the impaired
LTP observed in the absence of neuronal IRS-2. However, we
cannot exclude that p42/44 MAPK phosphorylation might be
reduced in response to LTP-inducing stimuli, thus also partici-
pating in the observed deficits in plasticity in IRS-2-deficient mice.
This seems indeed to be the case in global IRS-2 KO mice, where
activation of MAPK was not sustained 30 min after the induction
of LTP [94].
The multifunctional enzyme GSK-3 has recently emerged as a
regulator of hippocampal synaptic plasticity [74,75]. The GSK-3b
isoform, abundantly expressed in brain, has high constitutive
activity due to tyrosine phosphorylation and is inactivated by
further phosphorylation at Ser9. Activation of PI3K/Akt, such as
that induced by insulin/IGF-1 during glycogen metabolism, can
phosphorylate Ser9 and inhibit GSK-3b activity. Peineau and
colleagues [75] demonstrated an essential role for GSK-3b activity
in the induction of NMDA receptor-dependent LTD, while a
mouse model over-expressing active GSK-3b exhibited attenuated
LTP at CA1 synapses [74]. In keeping with these reports, our
findings establish for the first time a link between IRS-2 and GSK-
3b in neuronal function, and show that neuronal deficiency of
IRS-2 leads to an enhanced activation of GSK-3b, which in turn is
associated with impaired CA1 LTP.
minimize contamination from the AMPA-mediated component. E–I: Representative immunoblot images of hippocampal subfield CA1 lysates from
control (+/+) and NesCreIrs2KO mice (2/2) probed with antibodies against the total protein or specific phosphorylation sites of the AMPA receptor
subunit GluR1 (E–F) and the NMDA subunits NR1 (G), NR2A (H), and NR2B (I). Quantifications of immunoblots showing the protein level or relative
proportion of phosphorylated protein over the total are shown in the bar diagrams. E–F: The total level of the AMPA receptor subunit GluR1 was
similar in control (10068%) and NesCreIrs2KO mice (7769%, n=10, p=0.063; upper panels). E: The proportion of GluR1 subunit phosphorylated at
Ser845 (p-GluR1-S845) relative to total GluR1 protein was similar in control (10064%, n=5) and NesCreIrs2KO mice (9368%, n=5, p=0.46; middle
and lower panels). F: The proportion of GluR1 subunit phosphorylated at Ser831 (p-GluR1-S831) relative to total GluR1 protein was similar in
control (Ser831: 100613%; n=5) and NesCreIrs2KO mice (Ser831: 103618%, n=5; p=0.73; middle and lower panels). G: There was no change in
the total level of the NMDA receptor subunit NR1 (control mice: 100611%; NesCreIrs2KO mice: 9368%, n=5, p=0.46; upper panel). NesCreIrs2KO
mice displayed a reduced phosphorylation of NR1 at Ser897 (p-NR1; 4569%, n=6) relative to their control littermates (10069%, n=6, p,0.001;
middle and lower panels). H–I: There were no changes in the total levels of the NMDA receptor subunits NR2A (H; control mice: 100611%;
NesCreIrs2KO mice: 89611%, n=7, p=0.49), and NR2B (I; control mice: 100617%; NesCreIrs2KO mice: 129617%, n=5, p=0.55). Data are expressed as
mean 6 SEM. **p,0.01 (unpaired t-test).
doi:10.1371/journal.pone.0031124.g003
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PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e31124Figure 4. LTP and phosphorylation of Akt and GSK-3b are reduced in juvenile NesCreIrs2KO mice. A: LTP induced by a single TBS in slices
with intact inhibitory synaptic transmission was significantly reduced in juvenile NesCreIrs2KO mice (2/2; average EPSP slope change: 128611%,
N=5, n=7) compared to values obtained from littermate controls (+/+; average EPSP slope change: 16069%, N=7, n=7, p,0.05), 60 min following
induction. B: Representative EPSP traces (average of 4 consecutive sweeps) from individual experiments taken immediately prior to TBS, and
following 60 min of LTP in both control (+/+) and NesCreIrs2KO (2/2) mice. C: Immunoblot analysis from CA1 lysates showing that neither the total
level of p38MAPK nor the amount of phosphorylated p38MAPK (Thr180/Tyr182) are altered by brain-deletion of IRS-2 in NesCreIrs2KO (2/2; 10268%)
mice compared with control littermates (+/+; 100614%, n=5–7; p=0.91). The bar diagram on the right shows a summary of the data obtained from
5–7 mice per experimental group. D: Immunoblot analysis from CA1 specific lysates showing that neither the total level of p42/44 MAPK (ERK) nor the
amount of ERK phosphorylated at Thr202 and Tyr204 are altered by brain-deletion of IRS-2 in NesCreIrs2KO mice. For p42 MAPK: +/+ 10066.5%; 2/2
94.865.5%; n=5; p=0.56. For p44 MAPK: +/+ 10066.4%; 2/2 101.564.7%; n=5; p=0.86. E: Immunoblot analysis from CA1 lysates showing reduced
Akt/protein kinase B phosphorylation levels at Thr308 and Ser473 in NesCreIrs2KO mice (2/2; Ser473: 7468.%; Thr308: 6169%, n=7) compared to
controls (+/+; Ser473: 10068%; Thr308: 10069%, n=7; p=0.04 for Ser473, p=0.01 for Thr308). The bar diagram on the right shows a summary of the
data obtained from 7 mice per experimental group. F: Immunoblot analysis from CA1 lysates showing reduced phoshosphorylation of GSK-3b at Ser9
in NesCreIrs2KO mice (2/2;4 8 610%, n=5) compared to controls (+/+; 100610%, n=5; p=0.007). The bar diagram on the right shows a summary of
the data obtained from 5 mice per experimental group. Data are expressed as mean 6 SEM. *p,0.05; **p,0.01 (unpaired t-test).
doi:10.1371/journal.pone.0031124.g004
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PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e31124Metaplasticity is the modulation in the extent or direction of
synaptic plasticity by the previous activity of a synapse [78,99],
and it is thought to be important for cognitive processes and as a
safeguard against excitotoxicity [78,100]. In the hippocampus this
corresponds to the facilitation or suppression of LTP or LTD due
to prior activity-dependent priming of the same synapse induced
through transient facilitation of NMDA receptor activity [101]. A
striking finding is the inability to induce metaplasticity at CA1
synapses in NesCreIrs2KO mice, either through low-frequency
stimuli or manipulation of ionic conditions to favour NMDA
receptor activation. The molecular mechanisms underlying
metaplasticity are still largely unknown, but a likely explanation
for our finding is that, due to the tonic reduction in phospho-NR1,
our conditioning stimuli might not have been sufficient to reach
the threshold activation of NMDA receptors and rise in
intracellular Ca
2+ necessary to suppress subsequent LTP induction
in NesCreIrs2KO mice. Finally, an intriguing aspect of GSK-3b
signalling is its ability to modulate bi-directional plasticity. Indeed,
Figure 5. Metaplasticity cannot be induced in juvenile NesCreIrs2KO mice. A: A priming stimulus (10 Hz; small arrow) applied 20–30 min
prior to TBS (large arrow) significantly inhibited subsequent LTP induction in juvenile control mice (+/+) for at least 50 min (average EPSP slope
change: 10 Hz primed: 10464%, N=7, n=7), when compared to un-primed LTP recorded 50 min following induction (average EPSP slope change:
Control: 15869%, N=7, n=7, p,0.0005). B: In juvenile NesCreIrs2KO mice (2/2), the same priming stimulus (10 Hz; small arrow) did not affect TBS-
induced LTP (average EPSP slope change: 10 Hz primed; 13565%, N=7, n=10), compared with the un-primed LTP measured 50 min post-TBS
(average EPSP slope change: Control; 126611%, N=5, n=7; p=0.47). Insets in A and B show representative EPSP traces (average of 4 consecutive
sweeps) taken prior to and 50 min following TBS, from individual experiments in control (A) and NesCreIrs2KO (B) slices to which 10 Hz priming
stimuli had previously been applied. Scale bars: 0.4 mV; 10 ms. C: Enhancing NMDA receptor activity by lowering the concentration of extracellular
Mg
2+ to 1 mM and increasing the Ca
2+ concentration to 3 mM, caused an attenuation of TBS-induced LTP in juvenile control mice (+/+) (average EPSP
slope change: Low Mg
2+/High Ca
2+: 13563%, N=5, n=6) compared with LTP recorded for 60 min under standard ionic conditions (average EPSP
slope change: Control: 16069%, N=7, n=7, p,0.05). D: The same ionic conditions to enhance NMDA receptor activity did not significantly alter the
level of LTP obtained in NesCreIrs2KO mice (2/2) (average EPSP slope change: Low Mg
2+/High Ca
2+: 12764, N=4, n=5) compared with that
recorded in control conditions 60 min following induction (average EPSP slope change: Control: 128611%, N=5, n=7). E: Metaplasticity induced in
control mice (+/+) by altering extracellular divalent cation concentrations to enhance NMDA receptor activity yielded an LTP of similar magnitude to
that observed in NesCreIrs2KO mice (2/2) under the same conditions. F: Representative EPSP traces (average of 4 consecutive sweeps) from
individual experiments performed in low Mg
2+/high Ca
2+ conditions, taken prior to application of TBS and following 60 min of LTP in both control (+/
+) and NesCreIrs2KO (2/2) mice.
doi:10.1371/journal.pone.0031124.g005
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PLoS ONE | www.plosone.org 9 February 2012 | Volume 7 | Issue 2 | e31124the observation that LTP-inducing stimuli can inhibit GSK-3b
activity and thereby prevent subsequent induction of LTD [75],
suggests a role for this pathway in hippocampal metaplasticity.
The profound reduction in metaplasticity and the concomitant
dysregulation in GSK-3b basal phosphorylation in IRS-2 deficient
mice shown in this study suggest a link between metaplasticity and
GSK-3b function in the hippocampus. They further add IRS-2
signalling to the numerous pathways that have been shown to
affect the dynamic range of neural networks involved in learning
processes through the maintenance of a proper balance of LTP
and LTD, and metaplasticity induction [78].
Materials and Methods
Animals
Irs2lox mice were intercrossed with C57Bl6/J NesCre mice
(Jackson Laboratory) to generate compound heterozygous mice.
Double heterozygous mice were crossed with Irs2lox mice to obtain
wild-type, Irs2lox/lox, Cre and CreIrs2lox/lox mice. Mice lacking Irs2
in nestin-expressing cells were designated NesCreIrs2KO [40]. Mice
were handled in accordance to the Home Office Animal
Procedures Act (1986) and University College London Animal
Ethical Committee guidelines. All knockout and transgenic mice
were studied with appropriate littermate controls.
Hippocampal slice preparation
Acute hippocampal slices were prepared from control and
NesCreIrs2KO mice of either sex, ranging in age from 3–6 weeks
(Fig. 4, 5, 6) to 5–10 months (Fig. 1, 2, 3). Upon decapitation,
brains were rapidly dissected and removed in ice-cold, oxygenated
(95%O2/5%CO2) artificial cerebrospinal fluid (aCSF) containing
(in mM): 125 NaCl, 1.25 KCl, 1 CaCl2, 1.5 MgCl2, 1.25
KH2PO4, 25 NaHCO3, and 10 D-glucose. Transverse, dorsal
hippocampal slices (300 mm) were prepared using a VT1000S
vibroslicer (Leica, Germany), and incubated in an interface
chamber at room temperature for at least 1 hour prior to
experimentation. Slices were transferred to a submersion record-
ing chamber and superfused (2–3 ml/min) at room temperature
with oxygenated aCSF containing (in mM): 125 NaCl, 1.25 KCl, 2
CaCl2, 1.5 MgCl2, 1.25 KH2PO4, 25 NaHCO3, and 10 D-
glucose. A subset of experiments (Fig. 5C–F and Fig. 6) was
performed with lower extracellular MgCl2 (1 mM) and higher
CaCl2 (3 mM) concentrations. For experiments involving inhibi-
tion of GABAA receptor-mediated transmission, a surgical incision
was made between the CA3 and CA1 regions to minimise the
propagation of epileptiform activity. Older animals (5–10 months;
Fig. 1, 2, 3) had previously undergone behavioural training, at
least 1 month prior to slice preparation.
Whole-cell electrophysiological recordings
Gigaseal whole-cell recordings were obtained from somata of
CA1 pyramidal neurons. Borosilicate glass patch electrodes (4.5–
6.5 MV) were filled with an intracellular solution containing either
(in mM): 135 potassium gluconate, 10 KCl, 10 HEPES, 2 Na2-
ATP, 0.4 Na3-GTP, and 1 MgCl2, or (in mM): 135 cesium
gluconate, 10 NaCl, 10 HEPES, 1 MgCl2,2N a 2-ATP, 0.4 Na3-
GTP, 3 EGTA; pH was adjusted to 7.2–7.3 with KOH (potassium
gluconate solution) or NaOH (cesium gluconate solution);
osmolarity 280–300 mOsm. Once in the whole-cell configuration,
access resistance was regularly monitored and maintained at
#25 MV. Only cells with an initial resting membrane potential
between 255 and 275 mV were used, with no correction made
for liquid junction potential. Membrane resistance was determined
in response to a hyperpolarising step from 250 to 255 mV.
Action potentials were evoked by 1 s-long current injections (40–
400 pA). When recording whole-cell excitatory postsynaptic
currents, series resistance was compensated by 50–75%. The
Schaffer collateral-commissural pathway was stimulated (0.05 Hz)
using an extracellular electrode (,2M V) filled with aCSF.
Neurons were held in the voltage-clamp mode, at potentials of
+40 mV or 270 mV. All recordings were carried out at room
temperature (,22–23uC).
Extracellular electrophysiological recordings
The Schaffer collateral-commissural pathway was stimulated at
0.033 Hz (synaptic transmission) or 0.05 Hz (paired-pulse facili-
tation) and field excitatory postsynaptic potentials (EPSPs)
recorded from the CA1 stratum radiatum using extracellular
electrodes (described above). The stimulus intensity was adjusted
to produce a response ,50% of maximal EPSP amplitude as
determined from input–output curves performed at the beginning
of each experiment. A stable baseline of at least 10–20 min was
Figure 6. Metaplasticity cannot be induced in NesCreIrs2KO mice also under conditions that enhance NMDA receptor activity. A:A
priming stimulus (5 Hz; small arrow) applied 20 min prior to TBS (large arrow) induced further metaplasticity in control mice (+/+) (5 Hz primed,
60 min post TBS; average EPSP slope change: 11363%, N=3, n=5) compared with the un-primed values (Un-primed, 60 min post TBS; average EPSP
slope change: 13563%, N=5, n=6; p,0.00002), in the presence of 1 mM extracellular Mg
2+ and 3 mM extracellular Ca
2+ to enhance NMDA receptor
activity. B: The same priming protocol did not significantly alter TBS-induced LTP in NesCreIrs2KO mice (2/2) (5 Hz primed, 60 min post TBS; average
EPSP slope change: 12066%, N=3, n=5) when compared to un-primed values recorded 60 min following induction (Un-primed, 60 min post TBS;
average EPSP slope change: 12764, N=4, n=5). Insets in A and B show representative EPSP traces (average of 4 consecutive sweeps) taken prior to
and 60 min post-LTP induction. These traces are taken from individual experiments in control (A; +/+) and NesCreIrs2KO (B; 2/2) slices to which 5 Hz
priming stimuli had previously been applied in the presence of 1 mM extracellular Mg
2+ and 3 mM extracellular Ca
2+. Scale bars: A: 0.4 mV, 10 ms; B:
0.2 mV, 10 ms.
doi:10.1371/journal.pone.0031124.g006
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plasticity-inducing stimuli. Paired-pulse facilitation was evoked by
2 consecutive pulses of 0.2 ms duration, at an interval of 50 ms.
Two theta-burst stimulation protocols were used: the standard
theta-burst stimulation (TBS) consisted of 6 trains (4 pulses at
100 Hz) repeated at 5 Hz; the high-intensity theta burst
stimulation (H-TBS) corresponded to the TBS repeated twice
with a 2 min interval. Metaplasticity was evoked by a 10 Hz (10
pulses) priming stimulus, applied once or twice at a 2 min interval,
20–30 min prior to TBS (Fig. 5A,B), or by 5 Hz trains (5 pulses
repeated 20 times at 5 Hz intervals), 20 min prior to TBS (Fig. 6).
All recordings were carried out at room temperature (,22–23uC).
Data acquisition and analysis
All data were acquired using an EPC10 amplifier and Patch-
master software (HEKA). Action potential trains were filtered at
2.5 kHz and sampled at 12.5 kHz. Synaptic potentials were
filtered at 5 kHz and sampled at 20 kHz. Analysis was carried out
offline using PulseFit (HEKA), Igor Pro 4.03A and Neuromatic
(Wavemetrics Inc.; Dr. J. Rothman). Instantaneous firing frequen-
cy was determined by the reciprocal of the inter-spike interval
between consecutive action potentials. Spike frequency adaptation
was assessed as interval between the penultimate and last action
potentials, divided by that of the first and second action potentials.
Synaptic efficacy was determined as the measure of EPSP slope (10
to 80% of EPSP) or EPSC amplitude. LTP was assessed as
percentage EPSP slope, normalised to the mean slope recorded
during 5 minutes immediately prior to LTP induction. The
magnitude of LTP was determined as the mean % EPSP slope
recorded during the last 5 minutes of recording (either 50 min or
60 min post-TBS). PPF was assessed as the ratio of the slope of the
2
nd EPSP/1
st EPSP. AMPA receptor-EPSC amplitude was
measured as the average peak of 10 consecutive EPSC traces,
evoked at a holding potential of 270 mV. NMDA receptor-
mediated EPSC amplitude was measured as the average of 10
consecutive EPSC traces at +40 mV 50 ms post-stimulus, to
minimize contamination from AMPA receptor-mediated respons-
es (see for example [102–104]). Statistical comparisons were made
with two-tailed Student’s t-tests (paired or unpaired as appropri-
ate), using Excel (Microsoft) and InStat (GraphPad). ‘‘N’’ indicates
the number of animals and ‘‘n’’ the number of experiments (extra-
or intra-cellular recordings). In all cases, p,0.05 was considered
significant. ‘‘*’’ indicates p,0.05.
Protein lysate preparation and Western-blot analysis
Protein lysates were prepared from the microdissected hippo-
campal subfield CA1 at 4uC as previously described [105]. Protein
concentrations were determined by BCA assay (Perbio) using
bovine serum albumin (BSA) as standard. Equal amounts of protein
were separated on SDS-polyacrylamide gel electrophoresis (PAGE)
(pre-cast5%or10%polyacrylamidegels from Bio-Rad) followed by
electrophoretic transfer to polyvinyl difluoride membranes (Amer-
sham). Membranes were blocked with 5% non-fat dried milk in
Tris-buffered saline at room temperature and incubated over-night
at 4uC with primary antibodies. Horseradish peroxidase-conjugated
secondary antibodies (Amersham) were used as appropriate and
membranes developed with ECL Plus (Amersham). After detection
of phosphoproteins, membranes were stripped using Restore
Western Blot Stripping Buffer (Pierce) and reprobed with antibodies
against non-phosphorylated proteins. Band intensities were quan-
tified using the ImageJ software. Phosphoprotein levels were
normalized to total protein levels and expressed as percent values
relative to the control group. ‘‘n’’ indicates number of mice per
experimental group. Statistical comparisons were made with two-
tailed, unpaired Student’s t-tests, using GraphPad Prism. ‘‘*’’
indicates p,0.05; ‘‘**’’ indicates p,0.01. The following primary
antibodies were used: anti phospho Akt (Thr308 and Ser473,
1:1000), anti Akt(1:1000),anti phospho-GSK3b (Ser9, 1:1000), anti
GSK3b (1:1000), anti phospho-p42/44 MAPK (Thr202/Tyr204),
anti p42/44 MAPK (1:1000), anti phospho-p38 MAPK (Thr180/
Tyr182) and anti p38 MAPK (1:1000) from Cell Signaling
Technology; anti phospho NR1 (Ser897, 1:3000), anti NR1
(1:2000), anti NR2A (1:2500) and anti GLUR1 (1:10,000) from
Upstate Biotech; phospho GLUR1 (Ser 831, Ser845, 1:2000) and
anti NR2B (1:2500) from Chemicon.
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